Riverview Trust Company’s Zimmer Biomet ZBH Stock Holding History

Riverview Trust Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9	Closed	-$972	–	915
2024 Q3	$972	Sell	9 -114	-93%	-$12.4K	﹤0.01%	637
2024 Q2	$13.3K	Hold	123	–	–	0.01%	574
2024 Q1	$16.2K	Buy	+123	New	+$15.4K	0.01%	567
2023 Q4	–	Sell	-123	Closed	-$13.8K	–	654
2023 Q3	$13.8K	Hold	123	–	–	0.01%	589
2023 Q2	$17.9K	Hold	123	–	–	0.02%	409
2023 Q1	$15.9K	Hold	123	–	–	0.01%	436
2022 Q4	$16K	Hold	123	–	–	0.02%	407
2022 Q3	$13K	Sell	123 -55	-31%	-$6.04K	0.01%	550
2022 Q2	$19K	Hold	178	–	–	0.02%	413
2022 Q1	$23K	Buy	+178	New	+$21.5K	0.02%	446

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Riverview Trust Company's ZBH Position: Q4 2024 in Review

Riverview Trust Company sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 9 shares — an estimated $972 sold.

Riverview Trust Company first reported a position in ZBH in Q1 2022 and held it in 10 quarters. The position peaked at $23K in Q1 2022. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

Riverview Trust Company reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
Riverview Trust Company sold 9 Zimmer Biomet shares in Q4 2024, an estimated $972.
Riverview Trust Company first reported a position in Zimmer Biomet in Q1 2022 and held it in 10 quarters.
Riverview Trust Company's Zimmer Biomet position peaked at $23K in Q1 2022.
1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Riverview Trust Company's 13F filing for Q4 2024, filed 6 Feb 2025.